Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rudilla, David
PIMAGASOXMED, NCT04650061: PIMA - Individualized Adherence Improvement Plan	Recruiting	N/A	200	Europe	Motivational Interview (MI) & Adherence Follow-Up, Adherence Follow-Up	Air Liquide Healthcare Spain, Hospital Sao Joao, Hospital Pedro Hispano	Sleep Apnea, Obstructive	01/21	06/21
Landete, Pedro
Neptuno, NCT04784559 / 2020-005951-19: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection	Terminated	3	205	Europe, RoW	Plitidepsin, Dexamethasone, Remdesivir, Favipiravir	PharmaMar	COVID-19 Infection	03/23	03/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rudilla, David
PIMAGASOXMED, NCT04650061: PIMA - Individualized Adherence Improvement Plan	Recruiting	N/A	200	Europe	Motivational Interview (MI) & Adherence Follow-Up, Adherence Follow-Up	Air Liquide Healthcare Spain, Hospital Sao Joao, Hospital Pedro Hispano	Sleep Apnea, Obstructive	01/21	06/21
Landete, Pedro
Neptuno, NCT04784559 / 2020-005951-19: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection	Terminated	3	205	Europe, RoW	Plitidepsin, Dexamethasone, Remdesivir, Favipiravir	PharmaMar	COVID-19 Infection	03/23	03/23